MIMEDX GROUP, INC. (MDXG) › Cost of RevenueMIMEDX GROUP, INC. (MDXG) — Cost of RevenueAnnual figures by period end, from SEC filings.2016-12-31: $30.94M2017-12-31: $35.22M2018-12-31: $36.39M2019-12-31: $43.08M2020-12-31: $39.33M2021-12-31: $39.63M2022-12-31: $48.32M2023-12-31: $54.63M2024-12-31: $60.07M2025-12-31: $73.01M$73.01M2016-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$73.01M+21.5%2026-02-25From 2025-01-012024-12-31$60.07M+10.0%2026-02-25From 2024-01-012023-12-31$54.63M+13.1%2026-02-25From 2023-01-012022-12-31$48.32M+21.9%2025-02-26From 2022-01-012021-12-31$39.63M+0.8%2024-02-28From 2021-01-012020-12-31$39.33M-8.7%2023-02-28From 2020-01-012019-12-31$43.08M+18.4%2022-02-28From 2019-01-012018-12-31$36.39M+3.3%2021-03-08From 2018-01-012017-12-31$35.22M+13.8%2020-07-06From 2017-01-012016-12-31$30.94M—2020-03-17From 2016-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)